Prognostic and predictive value of ERβ1 and ERβ2 in the Intergroup Exemestane Study (IES)-first results from PathIES†. [electronic resource]
Producer: 20160609Description: 1890-1897 p. digitalISSN:- 1569-8041
- Aged
- Androstadienes -- therapeutic use
- Antineoplastic Agents -- therapeutic use
- Aromatase Inhibitors -- therapeutic use
- Biomarkers, Tumor -- genetics
- Breast Neoplasms -- drug therapy
- Disease-Free Survival
- Double-Blind Method
- Estrogen Receptor beta -- biosynthesis
- Female
- Humans
- Middle Aged
- Prognosis
- Proportional Hazards Models
- Retrospective Studies
- Tamoxifen -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.